Human serum amyloid A (SAA) is a major acute-phase reactant produced mainly by the liver. During periods of inflammation and tissue damage, serum levels of SAA can increase by up to 1,000-fold. SAA is also the precursor peptide of the amyloid A protein subunit of amyloid fibrils in secondary, or reactive, amyloidosis (24) . Insoluble fibrils are deposited extracellularly in multiple organs, compromising their normal function. This is a serious complication of chronic or recurrent inflammatory conditions, e.g., juvenile chronic arthritis, in which persistently high serum levels of SAA are found. More than one human SAA gene exist (16, 25, 41) , and in mice three active SAA genes and a pseudogene have been described (29, 51) . Both human and murine SAA gene expression can be induced by the cytokines interleukin-1 and tumor necrosis factor (39, 49) .
We have previously characterized a human SAA gene, SAAg9, and have demonstrated that expression of this gene can be induced by both of these cytokines in transfected mouse L cells (49) . How these factors mediate control of gene expression is unknown. To study the mechanism of the regulation of human SAA gene expression, we have characterized the 5'-flanking region of the gene by DNA sequence analysis. Using DNA constructs containing part of 5'-flanking region of SAA upstream of the reporter chloramphenicol acetyltransferase (CAT) gene, we have identified a phorbol ester-inducible enhancer region. We have demonstrated that a phorbol 12-myristate 13 -acetate (PMA)-inducible nuclear protein factor(s) binds to the sequence GG-GACTTTCC, a sequence first described by Sen and Baltimore (44) to bind the nuclear factor NFKB, and that this binding is required for enhancer activity. * 
MATERIALS AND METHODS
DNA sequence analysis. DNA sequence analysis was performed by the chain termination method of Sanger et al. (42) . DNA fragments from the 5'-flanking region of the SAA genomic clone, SAAg9 (49) , were subcloned into M13mpl8 and -mpl9 and sequenced by using sequence-specific oligonucleotides generated on an Applied Biosystems automated nucleotide synthesizer.
Plasmid-constructions. A 265-base-pair (bp) Sau3A DNA fragment, from the promoter region and 33 bp of the first exon of the human SAA gene, was cloned between the BglII-BamHI sites of the vector, pTK.CAT3 (31) . This construct contains the entire CAT gene, and the thymidine kinase promoter has been replaced with the SAA 5'-flanking region. As a control, the thymidine kinase promoter was deleted from pTK.CAT3 with BglII-BamHI. The subsequent constructs, OCAT/265 and OCAT, were used to study PMA inducibility conferred on the CAT gene by the SAA promoter region.
The 265-bp promoter fragment was also cloned into the BamHI site of the vector pBluescriptSK, generating plasmid 9-2. This vector contains both T3 and T7 promoters flanking the cloned insert, and it was used to generate both codingand noncoding-strand cRNA probes used for RNase mapping.
Wild-type (AGGGACTTTCC) and mutant (ACTCACTT TCC) NFKB-binding sequences from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) (32) , cloned into plasmid pGEM, were kindly provided by G. Nabel for cotransfection-competition studies.
Cell lines and DNA transfections. HeLa cells were cultured in minimal essential medium with 10% heat-inactivated fetal calf serum in 5% C02, and mouse L cells were cultured in Dulbecco modified Eagle medium with 10% heat-inactivated A   -1122  -1100  ETGCCCAGGC TGGGCCTCAA ATTCGGGT TCAAGCAGGC CTCCTGCCTT GGCCTCCCAA   GTAGCTGGGA CATATGGCAC ATGCCACCAT GCCTGGCCCA TTTCTAAATT GCTTGTTTGT   -1000  TTGTTATTAC AAATGCCTAG CCCCTCAGGG TATGAACATG GACTGGAGAA GAAGAAACCA   -900  GAGTTGCTGC TATGTCCACC AGCCTCTCTG CATGTCCTGG CCTCAGCCCC CCTGGGCTCT   GGTACTGACC CATCTCTGGC CACCATGCTC CTCCATAAGC CTCTGCAGAG fetal calf serum in 5% CO2. DNA transfections were performed by the calcium phosphate precipitation method (22) . OCAT, OCAT/265, and competitor DNAs were cotransfected with 2 ,ug of plasmid pXGH5 (43) , containing the growth hormone gene. At 24 h after transfection, the presence of secreted growth hormone was measured by radioimmunoassay (Allegro human growth hormone assay kit; Nichols Institute) to monitor the efficiency of DNA uptake by cells. The growth hormone assay was subsequently used to normalize the amount of cell extract used in the CAT assay. PMA was added 24 h after transfection, and cell extracts were generated at 28 h.
CAT assays. CAT assays were performed by a modification of the method described by Crabb and Dixon (13) , and values were normalized for transfection efficiency as mentioned above. After autoradiography, the acetylated and unacetylated forms of chloramphenicol were quantified by excision and then counting by liquid scintillation.
RNA isolation, RNase mapping, and Northern (RNA) blot analysis. Total RNA was isolated from semiconfluent petri dishes of transfected and nontransfected cells by the guanidinium isothiocyanate total cell lysis method (9) , and the RNA was purified by ultracentrifugation through a 5.7 M cesium chloride cushion.
T3 and T7 polymerases were used to generate coding-and noncoding-strand cRNA probes from recombinant 9-2, which contains 236 bp of 5' promoter sequence and 33 bp of the first exon of the SAA gene. These probes were then used for RNase mapping (30, 52 CCA GGG ------TATAAAT : : ::: 46bp (Fig. 1) .
First, there is a TATA box (sequence TATAAAT) between nucleotides -23 and -29 (Fig. 1A) .
Second, we found homology to alpha interferon (IFN-a) consensus sequence and the 5' region of the complement factor B gene (Fig. 1B) . Between -53 and -72, there is 81% homology to the IFN-a-responsive consensus element found in the IFN-a-inducible HLA and metallothionein genes (18) . The factor B gene, another acute-phase gene, contains a similar sequence (50) , showing 73% homology to the corresponding region in the SAA gene.
Third, the three mouse SAA genes contain a region of significant homology across 26 nucleotides in their 5'-flanking regions ( Fig. 1B; 29) . This homology is strongest between the mouse SAA1 and SAA2 genes. The human SAA gene contains a sequence bearing 73% homology to this region across 29 nucleotides, including the 26-nucleotide region of mouse SAA1 and SAA2. This homology is still 69% when the sequence region is extended to 41 nucleotides. Also striking are the similar spatial arrangements of the human and mouse homologies, all starting between nucleotides -72 and -76. However, the homology is only 50% when this region is compared with the corresponding region of mouse SAA3.
Fourth, the 11-nucleotide sequence AGGGACTTTCC, between -82 and -92, is contained within the sequence described above and is identical to the enhancer sequence (50) ; regions of homology are also found in the c-erb-A-binding site in the growth hormone gene (75%) (21) and the 5' region of the human apolipoprotein CIII gene (91%) (37) .
Fifth, between nucleotides -54 and -225 there are two inverted-repeat regions (21 and 19 bp) and two direct-repeat regions (Fig. 1A) . Also, the upstream portion of one of the direct-repeat regions bears 79% homology to a 5' repeat region of'the ,B-fibrinogen gene, another acute-phase gene (17) .
Finally, there is a consensus sequence consisting of 9 bp in the 5' region of SAA and the IL-1-inducible genes IL-6 (40) , stromelysin (37), complement factor B (50), a,-acid glycoprotein (AGP; 19) , and haptoglobin (33) (Fig. 1B) Fig. 3) , peaking at 8 ,ug but then decreasing slightly after this amount. It was also found that the OCAT/265 construct produced a significant, constitutive level of CAT activity. A dose-response curve, using 8 ,ug of OCAT/265 DNA, revealed maximum PMA induction of CAT activity at 50 ng/ml (data not shown).
To establish whether the transcriptional start site for the SAA-CAT gene construct is the same as the start site for the SAA gene, RNase mapping was performed on RNA isolated from cells transfected with both the whole gene and the OCAT/265 construct. The analyses revealed that transcription initiation occurred at exactly the same position when the whole SAA gene was used or when transcription was directed by just the 265-bp fragment on the CAT gene (Fig. 4) .
Specific DNA-binding nuclear protein induced by PMA. Since (i) PMA was capable of inducing transcription of the complete SAA gene and (ii) a short 5' region of the gene was capable of conferring inducibility to a heterologous reporter gene, DNA-binding proteins from PMA-treated cells were examined. We isolated total nuclear protein extracts from untreated and PMA-treated HeLa cells and assayed for DNA-binding activity by the DNA-binding gel shift assay. We found strong binding of nuclear proteins from the treated cells to the 265-bp 5' fragment capable of conferring PMA responsiveness (Fig. 5A) . Furthermore, this binding could be abolished by using 50 ng of unlabeled fragment as competitor. Binding could also be abolished by using an unlabeled HIV-1 LTR DNA fragment. This DNA fragment has been demonstrated to contain two binding sites for NFKB (32) . DNA binding was not affected when a nonspecific competitor, a 465-bp SAAg9 intron 1 DNA fragment, was used. We also studied nuclear binding proteins from mouse L cells persistently transfected with SAAg9. Specific binding to the 265-bp fragment was found with extracts from PMA-treated cells, and again the binding could be abolished with 50 ng of the HIV-1 LTR fragment (Fig. 5A) . electrophoresed through a nondenaturing 4% polyacrylamide gel, the gel was dried, and bands were visualized by autoradiography. Arrow indicates retarded band. Competitor DNAs: 265, 265-bp Sau3A 5' SAA fragment from SAAg9 (Fig. 1A) ; HIV, 361-bp EcoRV-BgIIH fragment of HIV-1 LTR DNA; Intron, 465-bp Avall intron 1 fragment of SAAg9. (B) The sequence of the protein-binding region was determined by methylation interference analysis. The 265-bp fragment was end labeled with 32P, the labeled ends were separated by SmaI digestion, and the DNA was partially methylated at G residues by incubation with dimethyl sulfate. A large-scale DNA-binding gel electrophoresis assay was performed on both fragments, and the bound and unbound DNAs were eluted from the gel. The DNA was then cleaved by incubation with piperidine, and the resultant DNA fraginents were separated by electrophoresis on a 12% polyacrylamide sequencing gel. Asterisks identify protected G residues. a region of DNA containing the viral enhancer sequence GGGACTITCC (Fig. SB) . This pattern of binding was similar to that described for the immunoglobulin enhancer binding factor NFKB, which is induced in HeLa cells by PMA. Induction of CAT activity with phorbol ester by the 5' SAA gene fragment is via binding of an NFKB-like factor. To establish whether the NFKB-like factor binding to the 5' SAA region was responsible for PMA-induced CAT activity, we cotransfected the OCAT/265 DNA construct with a fragment from the HIV-1 LTR containing two copies of the wild-type or mutant NFKB-binding site. This mutant sequence was previously shown to abolish the binding of NFKB transcription factor (32) . There was complete abolition of the PMA-inducible CAT activity with 50 ,ug of wild-type competitor DNA (Fig. 6 ). There was no competition when the cloned mutant NFKB-binding sequence was used.
DISCUSSION
The acute-phase response results in a dramatic change in the expression of a group of serum proteins. These changes can be induced in vivo and in vitro by treatment with cytokines individually or in combination. Examples include induction of SAA (39, 49) , complement factors B (36, 39) and C3 (14, 20) , AGP, and haptoglobin (20, 26, 39) by IL-1; induction of AGP (20, 38) , fibrinogen, al-antichymotrypsin, haptoglobin, cysteine protease inhibitor, and a2-macroglobulin (1, 20) by IL-6; induction of SAA (49) , complement C3, haptoglobin, and AGP (7, 20, 26) by tumor necrosis factor; and induction of complement factors B and C2 by IFN--y (47).
5' cis-acting control regions have been identified in a number of cytokine-responsive acute-phase genes. These include the IL-1-responsive factor B, AGP, haptoglobin, and stromelysin genes (19, 34, 38 ; H. R. Colten, personal communication) and the IL-6-responsive C-reactive protein gene (3 (48) . Furthermore, recent experiments (L. Osborn, S. Kunkel, and G. Nabel, Proc. Natl. Acad. Sci. USA, in press) have shown that IL-1 can induce transcription of CAT directed by the HIV-1 LTR via an NFKB-like factor. Our experiments demonstrate that PMA induces a moderate 5-fold increase in SAA mRNA, whereas IL-1 produces a >50-fold increase (49) . Therefore, PMA can mimic only part of the action of IL-1 in this system, and the 9-bp consensus sequence (Fig. 1B) The rapidity of SAA expression in the acute-phase response could be accounted for by activation of this region, since NFKB is present in the cytosol in an inactive state (4) and is rapidly activated and translocated to the nucleus upon stimulation of cells with phorbol ester. This process does not require any new protein synthesis (45) . However, NFKB has yet to be demonstrated in tissues that normally express SAA. Factors in cell types other than B, T, and HeLa that have DNA-binding properties very similar to those of NFKB have been identified. H2TF1, a factor found in most cell types, binds the sequence GGGGATTCCCC upstream of the mouse H-2Kb class I major histocompatibility gene (5) . Similarly, the phytohemagglutinin-and PMA-inducible nuclear protein HIVEN86A binds to the sequence GGGGAA TCTCCC, upstream of the IL-2 receptor alpha gene (8, 28) . NFKB also binds with high efficiency to both of these sequences (6, 8) . Moreover, the PMA-inducible factor AP-3 is able to bind an identical sequence in simian virus 40 but is slightly different in binding characteristics from NFKB (10) . Thus, several closely related protein factors are able to bind to subtly different 5' enhancer sequences, and any of these may be the true physiological activator for SAA gene transcription.
Other DNA-binding proteins have been shown to activate some other acute-phase genes; e.g., hepatocyte-specific nuclear factor 1 (HNF1) activates the at-and P-fibrinogen and a1-antitrypsin genes (12), major late transcription factor activates the rat -y-fibrinogen gene (11) , and LF-A1 and LF-B1 (or HNF1) activate the al-antitrypsin and haptoglobin genes (23) . However, binding sequences for these proteins are absent in the SAA promoter region. Also, the SAA gene does not contain the heat shock consensus sequence (35) found in the promoter regions of the C-reactive protein and factor B genes. Thus, a complex pattern of interactions between different, readily activatable nuclear factors and cis-acting DNA sequences of different acute-phase genes is now emerging. Future comparison of wild-type and mutant SAA genes should test directly the importance of these factors in the physiology of the acute-phase response.
